Dvt & pe
-
Upload
puneet-shukla -
Category
Documents
-
view
64 -
download
0
Transcript of Dvt & pe
DVT & PE
Deep vein thrombosis &
Pulmonary embolism
Deep vein thrombosis A form of thrombophlebitis Incidence- ~1 per 1000 persons per year Commonly affects leg veins (L>R)-
popliteal, femoral, pelvic Virchow’s triad- Decreased blood flow- stasis Damage to vessel wall Hypercoagulability Complication- Pulmonary embolism Post-phlebitic syndrome
DVT- risk factors Recent surgery Hospitalization Advanced age Obesity Immobilization Thrombophilia- AT-
III/protein C or S deficiency
Pregnancy Estrogen containing
OCP Tobacco use Prolonged economy
class air travel Cancer Infection
DVT-clinical presentation Underlying risk factors Symptoms Pain, swelling, redness of leg Superficial vein dilatation Signs Edema, tender veins Homan’s sign- calf pain on dorsiflexion of foot Acute DVT may cause impaired circulation
cold extremity, absent pulse, even gangrene
DVT- diagnosis
D-dimer level- a FDPDuplex ultrasonography, with
compressionCT venography (iliocaval DVT)
DVT- management Mostly out-patient, using LMWH Hospitalization recommended- B/L DVT Extensive proximal DVT CRI CHF Cancer Recent immobility Low body weight
Anticoagulation Low molecular weight heparin (LMWH) Fondaparinux Unfractionated heparin- requires
hospitalization & monitoring (aPTT)Dose- 80 U/kg bolus18 U/kg/hr infusionmonitor aPTT
Long-term Warfarin- at least 3 monthsDose- 5 mg OD x 3 daysmonitor PT Life-long for life-threatening/recurrent DVT Monitor PT/INR- 2-3 times normal
Other Rx options Thrombolysis for extensive proximal
clot, increases risk of bleeding
Intermittent pneumatic compression- (IPC) if heparin CI or post-op.
IVC filter- reduces PE, used in patients with ICH, potentially prothrombotic
DVT- prevention LMWH/UFH in hospitalised patients with risk
factors for DVT LMWH post-op. IPC after knee/hip surgery Elastic compression stockings during long-
haul flights Heparin/LMWH/Warfarin in at risk pregnancy Early mobil ization
Post-phlebitic syndrome Occurs in ~15% patients with DVT Consequences- Edema Pain Cramps Venous claudication Skin pigmentation Dermatitis Ulceration
Pulmonary embolism Commonly embolism from DVT
Risk more with proximal DVT
Risk factors- as for DVT
Clot obstructs pulmonary arterial circulation & strains right ventricle
PE- diagnosis Risk factors ± DVT Symptoms- Mostly silent ~15% of sudden deaths attributable to PE May cause sudden SOB, pleuritic chest pain,
hemoptysis Signs Tachypnea, cyanosis, pleural rub, low-grade fever RV strain- loud P2, LPSH, raised JVP
PE- diagnosis Investigations- CBC, PT/aPTT, LFT, RFT- for R/F CxR- mainly to rule out other pathology ECG- tachycardia, RV strain, R/O MI ECHO- RV dysfunction, R/O MI D-dimer ± US- for DVT CT pulmonary angiography- for PE Dx V-Q scan- contrast allergy/CI
PE- treatment Anticoagulation LMWH/Fondaparinux/Heparin Warfarin x minimum 3 months, lifelong if recurrent
Thrombolysis PE with hemodynamic instability PE with RV dysfunction on ECHO Surgical thrombectomy
H.I.T Heparin induced thrombocytopenia An immune reaction to Heparin/LMWH Paradoxical increase in arterial/venous
thrombosis, with thrombocytopenia Can occur upto 100 days after exposure Rx- Stop Heparin/LMWH Anticoagulation with direct thrombin inhibitors (monitor aPTT)-
lepirudin, argatroban, bivaluridin- until platelet count stabilizes
Long-term Warfarin